These benefits, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the notion of concentrating on ACKR3 as a novel method to modulate the opioid system, which could open new therapeutic avenues for opioid-connected Conditions.Study on conolidine is restricted, e